Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity

by Nugent, Summer L, Cunningham, Steven C, Alexiev, Borislav A, Bellavance, Emily, Papadimitriou, John C, Hanna, Nader
Published 2007

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients

by Zheng, Zhiyuan, Hanna, Nader, Onukwugha, Eberechukwu, Reese, Emily S, Seal, Brian, Mullins, C Daniel
Published 2014

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients

by Reese, Emily S, Onukwugha, Eberechukwu, Hanna, Nader, Seal, Brian S, Mullins, C Daniel
Published 2013

Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients

by Zheng, Zhiyuan, Onukwugha, Eberechukwu, Hanna, Nader, Bikov, Kaloyan, Seal, Brian, Mullins, C. Daniel
Published 2014

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery

by Katz, Steven, Point, Gary R., Cunetta, Marissa, Thorn, Mitchell, Guha, Prajna, Espat, N. Joseph, Boutros, Cherif, Hanna, Nader, Junghans, Richard P.
Published 2016

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

by Zhang, Geng, Schetter, Aaron, He, Peijun, Funamizu, Naotake, Gaedcke, Jochen, Ghadimi, B. Michael, Ried, Thomas, Hassan, Raffit, Yfantis, Harris G., Lee, Dong H., Lacy, Curtis, Maitra, Anirban, Hanna, Nader, Alexander, H. Richard, Hussain, S. Perwez
Published 2012